| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Morgan A Sammons
|
|||||||
| GSE111009 |
Cell type-dependent control of enhancer and p53 transcriptional activity by p63
|
98 | Morgan A Sammons | Feb 11, 2019 | ||||
| GSE115940 |
p53 binding and chromatin dynamics after etoposide treatment of primary lung fibroblast
|
11 | Morgan A Sammons | Jun 19, 2018 | ||||
| GSE137297 |
p53-bound enhancer elements require locally acting transcription factors
|
42 | Morgan A Sammons | Feb 24, 2020 | ||||
| GSE211244 |
RNAseq Analysis of TP53+/+ and TP53-/- HCT116 colon carcinoma cell lines after treatment with p53 or ATF4-activating compounds
|
30 | Morgan A Sammons | Aug 20, 2022 | ||||
| GSE233049 |
ATF3- and ZIKV-dependent transcriptome of A549 cells
|
12 | Morgan A Sammons | Jun 30, 2023 | ||||
| GSE266670 |
Context dependent activity of p63-bound gene regulatory elements
|
13 | Morgan A Sammons | May 08, 2024 | ||||
| GSE211264 |
Cut&Run Analysis of ATF4 genomic occupancy in HCT116 colon carcinoma cell lines after treatment with DMSO, etoposide, tunicamycin, or histidinol
|
24 | Morgan A Sammons | Aug 20, 2022 | ||||
| GSE226617 |
Saturating mutagenesis of the GADD45A intron 3 enhancer using STARRseq
|
7 | Morgan A Sammons | Mar 12, 2023 |
